Sildenafil for "blue babies"
- 16 November 2002
- Vol. 325 (7373) , 1174a-1174
- https://doi.org/10.1136/bmj.325.7373.1174/a
Abstract
# Such unlicensed drug use might be justified as last resort {#article-title-2} EDITOR—We were disappointed to hear that a doctor in India has been criticised for treating pulmonary hypertension in three neonates (so called blue babies) with the phosphodiesterase type 5 inhibitor sildenafil (Viagra), a drug not licensed for this purpose.1 Many drugs are widely and appropriately used outside their product licence.2 Such prescribing practice is common in adult medicine, but is particularly prevalent in paediatrics because companies rarely undertake the work necessary to gain a licence for children. The decision to prescribe outwith a drug's licence should be supported by evidence of safety and potential benefit and, when possible, by a reasonable body of supporting professional opinion. Of course, controlled clinical trials should be performed when possible to evaluate new treatments for specific indications. But these data are not always available, and then clinicians must make difficult decisions …Keywords
This publication has 8 references indexed in Scilit:
- Indian doctor in protest after using Viagra to save "blue babies"Published by BMJ ,2002
- Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial HypertensionCirculation, 2002
- Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Sildenafil (Viagra) in childhood and neonatal pulmonary hypertensionJournal of the American College of Cardiology, 2002
- Sildenafil Inhibits Hypoxia-Induced Pulmonary HypertensionCirculation, 2001
- Sildenafil Ameliorates Effects of Inhaled Nitric Oxide WithdrawalAnesthesiology, 1999
- Prescribing unlicensed drugs or using drugs for unlicensed indications.1992
- Prescribing unlicensed drugs or using drugs for unlicensed indicationsDrug and Therapeutics Bulletin, 1992